Donley Matthew Maxwell — SEC Form 4 filings
SEC reporting owner CIK 1636642. 6 Form 4 filings on record with FilingPulse; latest filed 2026-03-03.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-02-22 to 2026-03-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 2 filings — 165,558 shares, $1,218,489 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: sale of 65,902 shares @ $8.00 ($527,216) in Aurinia Pharmaceuticals Inc., filed 2025-03-04.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc. (AUPH) | Chief Operating Officer | 6 | — | 3 legs · 165,558 sh · $1,218,489 | 10 |
Form 4 filings — Donley Matthew Maxwell
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-03 | 4 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/award (A): 58,160 @ $0 · Tax withholding (F): 40,761 @ $14.21 · Grant/award (A): 97,256 (derivative) @ $0 | EDGAR |
| 2026-02-23 | 4 | Aurinia Pharmaceuticals Inc. (AUPH) | Tax withholding (F): 32,901 @ $14.40 | EDGAR |
| 2026-01-05 | 4 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/award (A): 54,166 @ $0 · Tax withholding (F): 42,787 @ $15.95 | EDGAR |
| 2025-03-04 | 4 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/award (A): 82,781 @ $0 · Grant/award (A): 135,567 @ $0 · Sale (S): 65,902 @ $8 · Sale (S): 58,991 @ $7.92 · Grant/award (A): 126,416 (derivative) @ $0 | EDGAR |
| 2024-03-07 | 4 | Aurinia Pharmaceuticals Inc. (AUPH) | Sale (S): 40,665 @ $5.51 | EDGAR |
| 2024-02-22 | 4 | Aurinia Pharmaceuticals Inc. (AUPH) | Grant/award (A): 216,666 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1636642 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →